Jump to the top of the page

Showing 460 – 470 of 1158 results

  • The Quarterly Rx Q2 2023 US Biopharma Recap

    Biopharma markets closed the first half of 2023 with renewed optimism and an encouraging outlook for the rest of the year.

  • Second Quarter Earnings Preview

    In this Economics Weekly, we break down the past quarter’s earnings and preview the main factors that we will be looking for from a macro perspective.

  • Sarah Tobolski

    View biography for Sarah Tobolski, senior investment associate.

  • Tyler Glover

    View biography for Tyler Glover, Partner, Managing Director, Private Wealth Management Consulting Services.

  • Thryv Holdings Inc Initiation

    William Blair & Company initiated research coverage of Thryv Holdings, Inc. (THRY $10.04). Thryv helps small and local businesses get discovered by customers.

  • Trean Insurance Group Inc Initiation

    William Blair & Company initiated research coverage of Trean Insurance Group, Inc. (TIG $16.70), which provides products and services to specialty insurance markets.

  • Cloudflare Inc Initiation

    William Blair & Company initiated research coverage of Cloudflare, Inc. (NET $36.12). The company provides a broad range of network services over its global cloud platform that enhance the security, performance, and reliability of business-critical applications while eliminating the cost and complexity of managing and integrating individual network hardware.

  • Silence Therapeutics plc

    William Blair & Company initiated research coverage of Silence Therapeutics plc (SLN $15.50), a clinical-stage biopharmaceutical company focused on developing proprietary GalNAc-conjugated siRNA therapeutics for genetically defined life-threatening disorders.

  • Cybersecurity 2020 Trust No One Verify Everyone

    The term zero trust has become the next in a long line of popular terms used by cybersecurity companies to associate their offerings with a more sophisticated, next-generation approach.

  • Rock 'n' Roll Inspires Philanthropy

    William Blair client Dr. Jeff Heddles shares his journey as a focal donor to help find a cure for a rare childhood disease.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures